PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

1,1'-(isopropylidene)bis[3,5-dibromo-4-(2,3-dibromopropoxy)benzene]

EC / List no: 244-617-5 CAS no: 21850-44-2
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Testing Proposal
Status
Concluded
Decision date
03-Mar-2016
Decision
Latest update
26-Nov-2022
Additional information
More information View
DEv 2
Scope
Comprehensive
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Germany
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Year
2017
Status
Concluded
Conclusion document
Latest update
08-Dec-2021
More information View
PBT - Persistent, bioaccumulative and toxic assessment
PBT 1
Authority
Germany
Status
Concluded
Outcome
not PBT
not vPvB
Hazard assessment outcome document
Remarks
The necessity for further action may need to be reassessed ones information on a possible impurity and metabolite TBBPA (EC number 201-236-9, CAS RN 79-94-7) becomes available. T assessment did not include Human Health hazards. Outcome based on CoRAP substance evaluation.
Concern
PBT (Article 57 d)
Date of intention
04-Nov-2015
Date of hazard assessment
08-Dec-2021
Latest update
20-Dec-2021
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
Germany
Status
Concluded
Outcome
postponed
Hazard assessment outcome document
Remarks
The eMSCA for the time being can neither conclude on the ED properties of TBBPA-DBPE and TBBPA-DBMPE not dismiss the concern based on the difficulty to request appropriate tests.

For TBBPA -the central building block for both substances- and their potential degradation product in the environment, a substance evaluation is currently ongoing which aims to clarify TBBPA’s potential for ED properties in the environment and its PBT/vPvB properties. Based on the outcome of the substance evaluation of TBBPA, the need for further testing for TBBPA-DBPE and TBBPA-DBMPE may need to be reassessed. Further information can be found in the SEv conclusion document.
Concern
Endocrine disruption
Date of intention
05-Dec-2017
Date of hazard assessment
Latest update
23-Jan-2023
More information View
Regulatory risk management
Assessment of regulatory needs
ARN 1
Authority
ECHA
Concern
Status
Under development
Follow-up
Pending action
Foreseen regulatory need
Restriction
Summary document
Group name
Tetrabromobisphenol A derivatives
Remarks
Date of intention
30-Aug-2021
Date of assessment
15-Dec-2021
Latest update
15-Mar-2023
More information View

List entry date: 22-Mar-2016

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.